Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection

BACKGROUND AND OBJECTIVE: Biologics for psoriasis, especially anti-tumor necrosis factor-α therapies, may reactivate hepatitis B virus (HBV) or hepatitis C virus (HCV) infections, as well in inactive carriers or patients with occult infection. However, some biologics, including anti-interleukin-17 t...

Descripción completa

Detalles Bibliográficos
Autores principales: Megna, Matteo, Patruno, Cataldo, Bongiorno, Maria Rita, Gambardella, Alessio, Guarneri, Claudio, Romita, Paolo, Raimondo, Annunziata, Loconsole, Francesco, Fabbrocini, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188589/
https://www.ncbi.nlm.nih.gov/pubmed/35633470
http://dx.doi.org/10.1007/s40261-022-01163-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188589/
https://www.ncbi.nlm.nih.gov/pubmed/35633470
http://dx.doi.org/10.1007/s40261-022-01163-5

Ejemplares similares